
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Phase I/ Phase II
Sponsor : Galapagos
Deal Size : $14.0 million
Deal Type : Acquisition
Galapagos to Acquire CellPoint And AboundBio to Accelerate Access to Next-Generation Cell Therapies
Details : The aim is to leverage CellPoint’s platform for novel CAR-Ts originating from AboundBio’s unique fully human antibody-based library and biological drug discovery and engineering capabilities, with the goal of bringing three next-generation CAR-T cand...
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
June 21, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Sponsor : Galapagos
Deal Size : $14.0 million
Deal Type : Acquisition
